+1 (704) 266-3234

Global Antibody-drug Conjugates Market Growth 2020-2025

Published on: Mar 2020 | From USD $3660 | Published By: LP INFORMATION INC. | Number Of Pages: 134

According to this study, over the next five years the Antibody-drug Conjugates market will register a 3.1% CAGR in terms of revenue, the global market size will reach $ 2926.2 million by 2025, from $ 2588.6 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antibody-drug Conjugates business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibody-drug Conjugates market by type, application, key manufacturers and key regions and countries.

This study considers the Antibody-drug Conjugates value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Adcetris
Kadcyla

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Breast Cancer
Lymphoma

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ImmunoGen
Seattle Genetics
Takeda
Roche
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Antibody-drug Conjugates consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Antibody-drug Conjugates market by identifying its various subsegments.
Focuses on the key global Antibody-drug Conjugates manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antibody-drug Conjugates with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Antibody-drug Conjugates submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antibody-drug Conjugates Consumption 2015-2025
2.1.2 Antibody-drug Conjugates Consumption CAGR by Region
2.2 Antibody-drug Conjugates Segment by Type
2.2.1 Adcetris
2.2.2 Kadcyla
2.3 Antibody-drug Conjugates Consumption by Type
2.3.1 Global Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
2.3.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2015-2020)
2.3.3 Global Antibody-drug Conjugates Sale Price by Type (2015-2020)
2.4 Antibody-drug Conjugates Segment by Application
2.4.1 Breast Cancer
2.4.2 Lymphoma
2.5 Antibody-drug Conjugates Consumption by Application
2.5.1 Global Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
2.5.2 Global Antibody-drug Conjugates Value and Market Share by Type (2015-2020)
2.5.3 Global Antibody-drug Conjugates Sale Price by Type (2015-2020)

3 Global Antibody-drug Conjugates by Company
3.1 Global Antibody-drug Conjugates Sales Market Share by Company
3.1.1 Global Antibody-drug Conjugates Sales by Company (2018-2020)
3.1.2 Global Antibody-drug Conjugates Sales Market Share by Company (2018-2020)
3.2 Global Antibody-drug Conjugates Revenue Market Share by Company
3.2.1 Global Antibody-drug Conjugates Revenue by Company (2018-2020)
3.2.2 Global Antibody-drug Conjugates Revenue Market Share by Company (2018-2020)
3.3 Global Antibody-drug Conjugates Sale Price by Company
3.4 Global Antibody-drug Conjugates Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Antibody-drug Conjugates Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Antibody-drug Conjugates Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Antibody-drug Conjugates by Regions
4.1 Antibody-drug Conjugates by Regions
4.2 Americas Antibody-drug Conjugates Consumption Growth
4.3 APAC Antibody-drug Conjugates Consumption Growth
4.4 Europe Antibody-drug Conjugates Consumption Growth
4.5 Middle East & Africa Antibody-drug Conjugates Consumption Growth

5 Americas
5.1 Americas Antibody-drug Conjugates Consumption by Countries
5.1.1 Americas Antibody-drug Conjugates Consumption by Countries (2015-2020)
5.1.2 Americas Antibody-drug Conjugates Value by Countries (2015-2020)
5.2 Americas Antibody-drug Conjugates Consumption by Type
5.3 Americas Antibody-drug Conjugates Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Antibody-drug Conjugates Consumption by Regions
6.1.1 APAC Antibody-drug Conjugates Consumption by Regions (2015-2020)
6.1.2 APAC Antibody-drug Conjugates Value by Regions (2015-2020)
6.2 APAC Antibody-drug Conjugates Consumption by Type
6.3 APAC Antibody-drug Conjugates Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Antibody-drug Conjugates by Countries
7.1.1 Europe Antibody-drug Conjugates Consumption by Countries (2015-2020)
7.1.2 Europe Antibody-drug Conjugates Value by Countries (2015-2020)
7.2 Europe Antibody-drug Conjugates Consumption by Type
7.3 Europe Antibody-drug Conjugates Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Antibody-drug Conjugates by Countries
8.1.1 Middle East & Africa Antibody-drug Conjugates Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Antibody-drug Conjugates Value by Countries (2015-2020)
8.2 Middle East & Africa Antibody-drug Conjugates Consumption by Type
8.3 Middle East & Africa Antibody-drug Conjugates Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Antibody-drug Conjugates Distributors
10.3 Antibody-drug Conjugates Customer

11 Global Antibody-drug Conjugates Market Forecast
11.1 Global Antibody-drug Conjugates Consumption Forecast (2021-2025)
11.2 Global Antibody-drug Conjugates Forecast by Regions
11.2.1 Global Antibody-drug Conjugates Forecast by Regions (2021-2025)
11.2.2 Global Antibody-drug Conjugates Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Antibody-drug Conjugates Forecast by Type
11.8 Global Antibody-drug Conjugates Forecast by Application

12 Key Players Analysis
12.1 ImmunoGen
12.1.1 Company Information
12.1.2 Antibody-drug Conjugates Product Offered
12.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 ImmunoGen Latest Developments
12.2 Seattle Genetics
12.2.1 Company Information
12.2.2 Antibody-drug Conjugates Product Offered
12.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Seattle Genetics Latest Developments
12.3 Takeda
12.3.1 Company Information
12.3.2 Antibody-drug Conjugates Product Offered
12.3.3 Takeda Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Takeda Latest Developments
12.4 Roche
12.4.1 Company Information
12.4.2 Antibody-drug Conjugates Product Offered
12.4.3 Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Roche Latest Developments
...

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Antibody-drug Conjugates Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Adcetris
Table 5. Major Players of Kadcyla
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Table 8. Global Antibody-drug Conjugates Revenue by Type (2015-2020) ($ million)
Table 9. Global Antibody-drug Conjugates Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Antibody-drug Conjugates Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Table 13. Global Antibody-drug Conjugates Value by Application (2015-2020)
Table 14. Global Antibody-drug Conjugates Value Market Share by Application (2015-2020)
Table 15. Global Antibody-drug Conjugates Sale Price by Application (2015-2020)
Table 16. Global Antibody-drug Conjugates Sales by Company (2017-2019) (Kg)
Table 17. Global Antibody-drug Conjugates Sales Market Share by Company (2017-2019)
Table 18. Global Antibody-drug Conjugates Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Antibody-drug Conjugates Revenue Market Share by Company (2017-2019)
Table 20. Global Antibody-drug Conjugates Sale Price by Company (2017-2019)
Table 21. Global Antibody-drug Conjugates Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Antibody-drug Conjugates Products Offered
Table 23. Antibody-drug Conjugates Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Antibody-drug Conjugates Consumption by Regions 2015-2020 (Kg)
Table 25. Global Antibody-drug Conjugates Consumption Market Share by Regions 2015-2020
Table 26. Global Antibody-drug Conjugates Value by Regions 2015-2020 ($ Millions)
Table 27. Global Antibody-drug Conjugates Value Market Share by Regions 2015-2020
Table 28. Americas Antibody-drug Conjugates Consumption by Countries (2015-2020) (Kg)
Table 29. Americas Antibody-drug Conjugates Consumption Market Share by Countries (2015-2020)
Table 30. Americas Antibody-drug Conjugates Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Antibody-drug Conjugates Value Market Share by Countries (2015-2020)
Table 32. Americas Antibody-drug Conjugates Consumption by Type (2015-2020) (Kg)
Table 33. Americas Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Table 34. Americas Antibody-drug Conjugates Consumption by Application (2015-2020) (Kg)
Table 35. Americas Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Table 36. APAC Antibody-drug Conjugates Consumption by Countries (2015-2020) (Kg)
Table 37. APAC Antibody-drug Conjugates Consumption Market Share by Countries (2015-2020)
Table 38. APAC Antibody-drug Conjugates Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Antibody-drug Conjugates Value Market Share by Regions (2015-2020)
Table 40. APAC Antibody-drug Conjugates Consumption by Type (2015-2020) (Kg)
Table 41. APAC Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Table 42. APAC Antibody-drug Conjugates Consumption by Application (2015-2020) (Kg)
Table 43. APAC Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Table 44. Europe Antibody-drug Conjugates Consumption by Countries (2015-2020) (Kg)
Table 45. Europe Antibody-drug Conjugates Consumption Market Share by Countries (2015-2020)
Table 46. Europe Antibody-drug Conjugates Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Antibody-drug Conjugates Value Market Share by Countries (2015-2020)
Table 48. Europe Antibody-drug Conjugates Consumption by Type (2015-2020) (Kg)
Table 49. Europe Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Table 50. Europe Antibody-drug Conjugates Consumption by Application (2015-2020) (Kg)
Table 51. Europe Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Antibody-drug Conjugates Consumption by Countries (2015-2020) (Kg)
Table 53. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Antibody-drug Conjugates Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Antibody-drug Conjugates Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Antibody-drug Conjugates Consumption by Type (2015-2020) (Kg)
Table 57. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Antibody-drug Conjugates Consumption by Application (2015-2020) (Kg)
Table 59. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Table 60. Antibody-drug Conjugates Distributors List
Table 61. Antibody-drug Conjugates Customer List
Table 62. Global Antibody-drug Conjugates Consumption Forecast by Countries (2021-2025) (Kg)
Table 63. Global Antibody-drug Conjugates Consumption Market Forecast by Regions
Table 64. Global Antibody-drug Conjugates Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Antibody-drug Conjugates Value Market Share Forecast by Regions
Table 66. Global Antibody-drug Conjugates Consumption Forecast by Type (2021-2025) (Kg)
Table 67. Global Antibody-drug Conjugates Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Antibody-drug Conjugates Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Antibody-drug Conjugates Value Market Share Forecast by Type (2021-2025)
Table 70. Global Antibody-drug Conjugates Consumption Forecast by Application (2021-2025) (Kg)
Table 71. Global Antibody-drug Conjugates Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Antibody-drug Conjugates Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Antibody-drug Conjugates Value Market Share Forecast by Application (2021-2025)
Table 74. ImmunoGen Product Offered
Table 75. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 76. ImmunoGen Main Business
Table 77. ImmunoGen Latest Developments
Table 78. ImmunoGen Basic Information, Company Total Revenue (in $ million), Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 79. Seattle Genetics Product Offered
Table 80. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 81. Seattle Genetics Main Business
Table 82. Seattle Genetics Latest Developments
Table 83. Seattle Genetics Basic Information, Company Total Revenue (in $ million), Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 84. Takeda Product Offered
Table 85. Takeda Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 86. Takeda Main Business
Table 87. Takeda Latest Developments
Table 88. Takeda Basic Information, Company Total Revenue (in $ million), Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
Table 89. Roche Product Offered
Table 90. Roche Antibody-drug Conjugates Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 91. Roche Main Business
Table 92. Roche Latest Developments
Table 93. Roche Basic Information, Company Total Revenue (in $ million), Antibody-drug Conjugates Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Antibody-drug Conjugates
Figure 2. Antibody-drug Conjugates Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Antibody-drug Conjugates Consumption Growth Rate 2015-2025 (Kg)
Figure 5. Global Antibody-drug Conjugates Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Adcetris
Figure 7. Product Picture of Kadcyla
Figure 8. Global Antibody-drug Conjugates Consumption Market Share by Type (2015-2020)
Figure 9. Global Antibody-drug Conjugates Value Market Share by Type (2015-2020)
Figure 10. Antibody-drug Conjugates Consumed in Breast Cancer
Figure 11. Global Antibody-drug Conjugates Market: Breast Cancer (2015-2020) (Kg)
Figure 12. Global Antibody-drug Conjugates Market: Breast Cancer (2015-2020) ($ Millions)
Figure 13. Antibody-drug Conjugates Consumed in Lymphoma
Figure 14. Global Antibody-drug Conjugates Market: Lymphoma (2015-2020) (Kg)
Figure 15. Global Antibody-drug Conjugates Market: Lymphoma (2015-2020) ($ Millions)
Figure 16. Global Antibody-drug Conjugates Consumption Market Share by Application (2015-2020)
Figure 17. Global Antibody-drug Conjugates Value Market Share by Application (2015-2020)
Figure 18. Global Antibody-drug Conjugates Sales Market Share by Company in 2017
Figure 19. Global Antibody-drug Conjugates Sales Market Share by Company in 2019
Figure 20. Global Antibody-drug Conjugates Revenue Market Share by Company in 2017
Figure 21. Global Antibody-drug Conjugates Revenue Market Share by Company in 2019
Figure 22. Global Antibody-drug Conjugates Sale Price by Company in 2019
Figure 23. Global Antibody-drug Conjugates Consumption Market Share by Regions 2015-2020
Figure 24. Global Antibody-drug Conjugates Value Market Share by Regions 2015-2020
Figure 25. Americas Antibody-drug Conjugates Consumption 2015-2020 (Kg)
Figure 26. Americas Antibody-drug Conjugates Value 2015-2020 ($ Millions)
Figure 27. APAC Antibody-drug Conjugates Consumption 2015-2020 (Kg)
Figure 28. APAC Antibody-drug Conjugates Value 2015-2020 ($ Millions)
Figure 29. Europe Antibody-drug Conjugates Consumption 2015-2020 (Kg)
Figure 30. Europe Antibody-drug Conjugates Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Antibody-drug Conjugates Consumption 2015-2020 (Kg)
Figure 32. Middle East & Africa Antibody-drug Conjugates Value 2015-2020 ($ Millions)
Figure 33. Americas Antibody-drug Conjugates Consumption Market Share by Countries in 2019
Figure 34. Americas Antibody-drug Conjugates Value Market Share by Countries in 2019
Figure 35. Americas Antibody-drug Conjugates Consumption Market Share by Type in 2019
Figure 36. Americas Antibody-drug Conjugates Consumption Market Share by Application in 2019
Figure 37. United States Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 38. United States Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 40. Canada Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 42. Mexico Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Antibody-drug Conjugates Consumption Market Share by Countries in 2019
Figure 44. APAC Antibody-drug Conjugates Value Market Share by Regions in 2019
Figure 45. APAC Antibody-drug Conjugates Consumption Market Share by Type in 2019
Figure 46. APAC Antibody-drug Conjugates Consumption Market Share by Application in 2019
Figure 47. China Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 48. China Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 50. Japan Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 52. Korea Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 54. Southeast Asia Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 55. India Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 56. India Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 58. Australia Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Antibody-drug Conjugates Consumption Market Share by Countries in 2019
Figure 60. Europe Antibody-drug Conjugates Value Market Share by Countries in 2019
Figure 61. Europe Antibody-drug Conjugates Consumption Market Share by Type in 2019
Figure 62. Europe Antibody-drug Conjugates Consumption Market Share by Application in 2019
Figure 63. Germany Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 64. Germany Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 65. France Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 66. France Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 67. UK Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 68. UK Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 70. Italy Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 72. Russia Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 73. Spain Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 74. Spain Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 75. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Countries in 2019
Figure 76. Middle East & Africa Antibody-drug Conjugates Value Market Share by Countries in 2019
Figure 77. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Type in 2019
Figure 78. Middle East & Africa Antibody-drug Conjugates Consumption Market Share by Application in 2019
Figure 79. Egypt Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 80. Egypt Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 81. South Africa Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 82. South Africa Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 83. Israel Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 84. Israel Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 85. Turkey Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 86. Turkey Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 87. GCC Countries Antibody-drug Conjugates Consumption Growth 2015-2020 (Kg)
Figure 88. GCC Countries Antibody-drug Conjugates Value Growth 2015-2020 ($ Millions)
Figure 89. Global Antibody-drug Conjugates Consumption Growth Rate Forecast (2021-2025) (Kg)
Figure 90. Global Antibody-drug Conjugates Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 91. Americas Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 92. Americas Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 93. APAC Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 94. APAC Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 95. Europe Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 96. Europe Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 97. Middle East & Africa Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 98. Middle East & Africa Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 99. United States Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 100. United States Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 101. Canada Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 102. Canada Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 103. Mexico Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 104. Mexico Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 105. Brazil Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 106. Brazil Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 107. China Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 108. China Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 109. Japan Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 110. Japan Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 111. Korea Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 112. Korea Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 113. Southeast Asia Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 114. Southeast Asia Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 115. India Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 116. India Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 117. Australia Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 118. Australia Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 119. Germany Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 120. Germany Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 121. France Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 122. France Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 123. UK Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 124. UK Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 125. Italy Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 126. Italy Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 127. Russia Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 128. Russia Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 129. Spain Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 130. Spain Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 131. Egypt Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 132. Egypt Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 133. South Africa Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 134. South Africa Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 135. Israel Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 136. Israel Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 137. Turkey Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 138. Turkey Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 139. GCC Countries Antibody-drug Conjugates Consumption 2021-2025 (Kg)
Figure 140. GCC Countries Antibody-drug Conjugates Value 2021-2025 ($ Millions)
Figure 141. ImmunoGen Antibody-drug Conjugates Market Share (2018-2020)
Figure 142. Seattle Genetics Antibody-drug Conjugates Market Share (2018-2020)
Figure 143. Takeda Antibody-drug Conjugates Market Share (2018-2020)
Figure 144. Roche Antibody-drug Conjugates Market Share (2018-2020)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3660
USD $5490
USD $7320
Offer

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.